David McCall, MD

Peer-Reviewed Articles

1. Meng, C, Huen, A, McCall, DC, Aung, PP, Nagarajan, P, Nardi, V, Torres Cabala, CA. Pediatric Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma With Unusually Long Clinical Course. Journal of cutaneous pathology 53(4):340-346, 2026. e-Pub 2026. PMID: 41400112.
2. Catueno, S, Frost, M, Cuglievan, B, Gibson, A, McCall, DC, Nunez, CA, Roth, M, Malpica Castillo, LE, Garcia, MB. Uncommon Presentation and Therapeutic Strategies in Pediatric Relapsed/Refractory ALK-Positive ALCL. Journal of Pediatric Hematology/Oncology 48(3):125-127, 2026. e-Pub 2026. PMID: 41818168.
3. McCall D. Optimizing safety and efficacy of asparaginase and blinatumomab therapy in frontline acute lymphoblastic leukemia regimens in diverse healthcare settings – international expert consensus, 2026. e-Pub 2026.
4. Garcia, MB, Wang, B, Sheikh, IN, El Hajjar, G, McCall, DC, Nunez, CA, Gibson, A, Lorenzi, PL, Issa, GC, Cuglievan, B, Abbas, HA. High-Throughput Proteomic Profiling to Evaluate Differentiation Syndrome With Menin Inhibition. Molecular and Cellular Proteomics 25(3), 2026. e-Pub 2026. PMID: 41621809.
5. Frost M, Elgehiny A, Dobbins C, Saleh A, Rosemore C, Hajjar J, Abbas HA, McCall D. Midostaurin-cladribine therapy for neonatal aggressive systemic mastocytosis. Pediatric Blood & Cancer. e-Pub 2026.
6. McCall D. High-Throughput Proteomic Profiling to Evaluate Differentiation Syndrome With Menin Inhibition, 2026. e-Pub 2026.
7. Olayinka Okeleji, David McCall. IMMUNE-RELATED TOXICITY PROFILE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH B-ALL GIVEN COMBINATION IMMUNOTHERAPY WITH RITUXIMAB, INOTUZUMAB, AND BLINATUMOMAB, 2026. e-Pub 2026.
8. Raj, R, Catueno, S, Gibson, A, McCall, DC, Garcia, MB, Nunez, CA, Roth, M, Sasaki, K, Tewari, P, Issa, GC, Farhat, A, Connors, JS, Sheikh, IN, Nishida, Y, Yi, JS, Stevens, A, Bataller Torralba, A, Bhalla, K, Petropoulos, D, Daver, N, Kadia, TM, Cuglievan, B, DiNardo, C. FLAG-IDA plus venetoclax for children, adolescents, and young adults with newly diagnosed AML. Blood 146(21):2608-2611, 2025. e-Pub 2025. PMID: 40971491.
9. McCall, DC, Karol, S, Short, NJ. The Need for Concurrent Chemoimmunotherapy in Pediatric B-Cell Lymphoblastic Leukemia. Acta haematologica 148(6):607-609, 2025. e-Pub 2025. PMID: 40058347.
10. Catueno, S, Ramakrishnan, R, Elitzur, S, Garcia, MB, McCall, DC, Nunez, CA, Roth, M, Ferrajoli, A, Cuglievan, B, Gibson, A. Lymphoid Malignancies in Ataxia–Telangiectasia. Pediatric Blood and Cancer 72(9), 2025. e-Pub 2025. PMID: 40605148.
11. Corrigan, KL, Berkman, AM, Gunther, J, Andersen, C, Wu, SY, Gibson, A, Cuglievan, B, Garcia, MB, Manzar, G, Fang, PQ, De, BS, Ahmed, S, Nunez, CA, Hildebrandt, MA, McCall, DC, Parsons, SK, Roth, M. Trends in Radiation Use from 2004 to 2020 among Adolescents and Young Adults with Hodgkin Lymphoma. Cancer Epidemiology Biomarkers and Prevention 34(9):1483-1491, 2025. e-Pub 2025. PMID: 40488452.
12. McCall D, Cohen, E, Okeleji, O, McCall, D, Garcia, M, Nunez, C, Cuglievan, B, Herzog, C, Razvi, S, Tewari, P, Douglas, H, Gibson, A. Synchronous mediastinal germ cell tumor with sarcomatous transformation and acute myeloid leukemia. Pediatric Blood & Cancer. e-Pub 2025.
13. McCall D, Raj, R, Catueno, S, Gibson, A, McCall, Garcia, M B, Nunez, C, Roth, M, Sasaki, K, Tewari, P, Issa, G C, Farhat, A, Connors, J, Sheikh, I, Nishida, Y, Bataller, A, Bhalla, K, Petropoulos, D, Daver, N, Kadia, T, Cuglievan, B, Kantarjian, H, DiNardo, C D. FLAG-IDA plus venetoclax for children, adolescents, and young adults with newly diagnosed AML. e-Pub 2025.
14. Berkman, AM, Andersen, C, Puthenpura, V, Short, NJ, Merriman, K, Swaminathan, M, Cuglievan, B, McCall, DC, DiNardo, C, Nunez, CA, Jain, N, Kadia, TM, Issa, GC, Gibson, A, Garcia, MB, Andrew Livingston, J, Parsons, SK, Hildebrandt, MA, Roth, M. Risk of early death after acute leukemia diagnosis among adolescents and young adults. JNCI Cancer Spectrum 9(4), 2025. e-Pub 2025. PMID: 40579211.
15. Elgehiny, A, Hsu, A, McCall, DC, Gibson, A, Cuglievan, B, Nunez, CA, Garcia, MB, Castellanos, LE, Funck, A, Razvi, S. Severe Hypertriglyceridemia Secondary to Long-acting Asparaginase in Pediatric Patients With Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology 47(6):e215-e221, 2025. e-Pub 2025. PMID: 40560745.
16. He, J, Munir, F, Ayerbe, C, Dickson, S, Catueno, S, Cuglievan, B, Gibson, A, McCall, DC, Nunez, CA, Roth, M, Tewari, P, Garcia, MB, Rodriguez, NI, Cortes, JA. Managing and Preventing Hypofibrinogenemia in Pediatric and AYA Leukemia Patients. Journal of Pediatric Hematology/Oncology 47(5):235-241, 2025. e-Pub 2025. PMID: 40306291.
17. McCall D, Elgehiny, Hsu, McCall, Gibson, Cuglievan, Nunez, Garcia, Castellanos, Funck, Razvi. Severe hypertriglyceridemia secondary to long-acting asparaginase in pediatric patients with acute lymphoblastic leukemia. e-Pub 2025.
18. McCall D, Catueno, S, Ramakrishnan, R, Elitzur, S, Garcia, M B, McCall, D, Nunez, C, Roth, M, Ferrajoli, A, Cuglievan, B, Gibson, A. Lymphoid malignancies in Ataxia-telangiectasia: Experience with novel targeted therapies. e-Pub 2025.
19. Berkman, A, Andersen, C R, Puthenpura, V, Short, N, Merriman, K, Swaminathan, M, Cuglievan, B, McCall, D, DiNardo, C, Nunez, C, Jain, N, Kadia, T, Issa, G, Gibson, A, Garcia, M, Livingston, J A, Parsons, S, Hildebrandt, M, Roth, M E. Risk of early death after acute leukemia diagnosis among adolescents and young adults. e-Pub 2025.
20. McCall D, Corrigan, K L, Berkman, A M, Gunther, J, Andersen, C R, Wu, S, Gibson, A, Cuglievan, B, Garcia, M B, Manzar, G, Fang, P, De, B, Ahmed, S, Nunez, C, Hildebrandt, M A, McCall, D C, Parsons, S K, Roth, M. Trends in radiation use from 2004–2020 among adolescents and young adults with Hodgkin lymphoma. e-Pub 2025.
21. McCall D, He, J, Munir, F, Ayerbe, C, Dickson, S, Catueno, S, Cuglievan, B, Gibson, A, McCall, D, Nunez, C, Roth, M, Tewari, P, Garcia, M, Rodriguez, N, Cortes, J. Managing and preventing hypofibrinogenemia in pediatric and AYA leukemia patients: Insights from MD Anderson Cancer Center. e-Pub 2025.
22. Nash, A, Dinh, CN, Kawedia, J, McCall, DC, Weinman, S, Garcia, M, Roth, M, Nunez, CA, Cuglievan, B, Gibson, A. Calasparagase Pegol Induced Hemolytic Anemia. Pediatric Blood and Cancer 72(3), 2025. e-Pub 2025. PMID: 39757556.
23. Sheikh, IN, Uwaezuoke, D, Okeleji, O, Quesada, AE, Herzog, CE, Ragoonanan, D, Tewari, P, Petropoulos, D, McCall, DC, Nunez, CA, Roth, M, Cuglievan, B, Khazal, SJ. Treatment of a Pediatric Patient with Core Binding Factor Acute Myeloid Leukemia Post-Cytotoxic Therapy With Cytarabine, Daunorubicin, and Gemtuzumab Followed by Stem Cell Transplantation. Pediatric Blood and Cancer 72(3), 2025. e-Pub 2025. PMID: 39702892.
24. McCall D, Olayinka Okeleji, Amber Gibson, Miriam B. Garcia, Cesar Nunez, Michael E. Roth, Jeremy Conners, Demetrios Petropolous, Priti Tewari, Branko Cugelivan, Iritiza Sheikh. Blood Advances: MENIN maintenance therapy for acute leukemia. e-Pub 2025.
25. Inaba, H, Teachey, DT, Annesley, CE, Batra, S, Beck, J, Colace, S, Cooper, S, Dallas, M, De Oliveira, SN, Kelly, KM, Kitko, C, Kohorst, MA, Kutny, M, Lacayo, NJ, Lee-Miller, C, Ludwig, K, Madden, L, Maloney, K, Mangum, S, Massaro, S, McCall, DC, Morocco, P, Muller, B, Murphy, L, Nardi, V, Rossoff, J, Schuettpelz, LG, Shah, BD, Sun, J, Wong, V, Yanik, G, Awotiwon, A, Stehman, K. Pediatric Acute Lymphoblastic Leukemia, Version 2.2025. JNCCN Journal of the National Comprehensive Cancer Network 23(2):41-62, 2025. e-Pub 2025. PMID: 39938467.
26. McCall D, Nash AP, Nguyen Dinh C, Kawedia J, McCall D, Weinman SD, Garcia MB, Roth M, Nunez CA, Cuglievan B, Gibson A. Pediatric Blood & Cancer: Calasparagase pegol induced hemolytic anemia. e-Pub 2024.
27. Inaba H, Teachey D, Annesley C, Batra S, Beck J, Colace S, Cooper S, Dallas M, De Oliveira S, Kelly K, Kitko C, Kohorst M, Kutny M, Lacayo N, Lee-Miller C, Ludwig K, Madden L, Maloney K, Mangum D, Massaro S, McCall D, Morocco P, Muller B, Murphy L, Nardi V, Rossoff J, Schuettpelz L, Shah B, Sun J, Wong V, Yanik G, Awotiwon A, Stehman K. Pediatric Acute Lymphoblastic Leukemia v2.2025. e-Pub 2024.
28. McCall, Alqahtani, Budak, Sheikh, Fan, Ramakrishnan, Nunez, Roth, Garcia, Gibson, Daver, Garces, Short, Issa, Ravandi, DiNardo, Bravo M, Cuglievan. Cladribine-based therapy for acute myeloid leukemia in child, adolescent, and early young adult patients. Cancers, 2024. e-Pub 2024.
29. Gibson, A, Dickson, S, McCall, DC, Garcia, M, Connors, JS, He, J, Roth, M, Nunez, CA, Cuglievan, B. Venetoclax for pediatric patients with newly diagnosed acute myeloid leukemia. Pediatric Blood and Cancer 71(11), 2024. e-Pub 2024. PMID: 39152634.
30. McCall, DC, Alqahtani, S, Budak, M, Sheikh, IN, Fan, AE, Ramakrishnan, R, Nunez, CA, Roth, M, Garcia, M, Gibson, A, Daver, N, Garces, S, Short, NJ, Issa, GC, Ravandi-Kashani, F, DiNardo, C, Montalban Bravo, G, Garcia-Manero, G, Cuglievan, B, Kadia, TM. Cladribine-Based Therapy for Acute Myeloid Leukemia in Child, Adolescent, and Early Young Adult Patients. Cancers 16(22), 2024. e-Pub 2024. PMID: 39594839.
31. Cuglievan, B, Kantarjian, HM, Rubnitz, JE, Cooper, T, Zwaan, CM, Pollard, J, DiNardo, C, Kadia, TM, Guest, E, Short, NJ, McCall, DC, Daver, N, Nunez, CA, Haddad, FG, Garcia, MB, Bhalla, K, Maiti, A, Catueno, S, Fiskus, WC, Carter, BZ, Gibson, A, Roth, M, Khazal, SJ, Tewari, P, Abbas, HA, Bourgeois, W, Andreeff, M, Shukla, N, Truong, D, Connors, JS, Ludwig, JA, Stutterheim, J, Salzer, E, Juul-Dam, KL, Sasaki, K, Mahadeo, KM, Tasian, SK, Borthakur, G, Dickson, S, Jain, N, Jabbour, EJ, Meshinchi, S, Garcia-Manero, G, Ravandi, F, Stein, EM, Kolb, EA, Issa, GC. Menin inhibitors in pediatric acute leukemia. Leukemia 38(10):2073-2084, 2024. e-Pub 2024. PMID: 39179671.
32. Gibson, A, Nunez, CA, Robusto, L, Kammerer, B, Garcia, M, Roth, M, Sheth, RK, Tewari, P, Hittle, A, Toepfer, L, Torres, R, Short, NJ, Jabbour, EJ, Jain, N, Cuglievan, B, McCall, DC. Combination low-intensity chemotherapy plus inotuzumab ozogamicin, blinatumomab and rituximab for pediatric patients with relapsed/refractory B-cell acute lymphoblastic leukemia. Haematologica 109(9):3042-3047, 2024. e-Pub 2024. PMID: 38779719.
33. Nash, A, Weirda, WG, Albritton, KH, Cuglievan, B, Garcia, MB, McCall, DC, Nunez, CA, Gibson, A. Rare case of chronic lymphocytic leukemia in an adolescent treated with targeted therapy. Pediatric Blood and Cancer 71(9), 2024. e-Pub 2024. PMID: 38872414.
34. McCall, DC, Abuasab, T, Rodriguez-Sevilla, JJ, Mohamed, SF, Patnaik, A, Devireddy, K, Arani, N, Sheikh, IN, Jamshidi, R, Gibson, A, Roth, M, Nunez, CA, Garcia, M, Chien, KS, Loghavi, S, Pierce, S, Sasaki, K, Issa, GC, Cuglievan, B, Kantarjian, H, Garcia-Manero, G. Characteristics and outcomes of children, adolescent, and young adult patients with myelodysplastic neoplasms. Leukemia Research 144, 2024. e-Pub 2024. PMID: 39178611.
35. Wolfson, JA, Davis, ES, Saha, A, Martinez, I, McCall, DC, Kothari, P, Brackett, J, Dickens, DS, Kahn, AR, Schwalm, C, Sharma, A, Richman, J, Cuglievan, B, Bhatia, S, Dai, C, Levine, J, Johnston, E, Aftandilian, C, Agrawal, AK, DeAngulo, G, Aristizabal, P, Bailey, K, Bardwell, JK, Becton, DL, Bemrich-Stolz, C, Boal, LH, Boston, CW, Bradfield, SM, Caywood, EH, Chou, AJ, Cohn, SM, Colace, SI, Coven, SL, Cramer, SL, Dargart, JL, Daghistani, D, Dhir, A, Dumitriu, A, Eslin, D, Esquilin, JM, Feinberg, S, Ferdjallah, A, Fernández, KS, Fixler, J, Foley, J, Gampel, BH, Glasser, CL, Goodman, JF, Gotesman, M, Gowans, LK. Adolescents and young adults with cancer. Journal of the National Cancer Institute 116(8):1366-1373, 2024. e-Pub 2024. PMID: 38627241.
36. Okeleji, O, Gibson, A, Nunez, CA, Garcia, MB, Roth, M, Cuglievan, B, McCall, DC. Novel immunotherapeutic approaches for pediatric classical Hodgkin lymphoma. Pediatric Blood and Cancer 71(8), 2024. e-Pub 2024. PMID: 38840433.
37. Alqahtani, S, Ramakrishnan, R, Shuyu, E, Wang, S, Nunez, CA, McCall, DC, Garcia, MB, Roth, M, Cuglievan, B, Gibson, A. Venetoclax use in a patient with ataxia telangiectasia and early T-cell precursor acute lymphoblastic leukemia. Pediatric Blood and Cancer 71(8), 2024. e-Pub 2024. PMID: 38837565.
38. Sarkar, S, Rav, ES, Stitzlein, LM, Gibson, A, McCall, DC, Nunez, CA, Roth, M, Ragoonanan, D, Connors, JS, Herzog, CE, Cuglievan, B, Garcia, MB. Palbociclib and chemotherapy followed by blinatumomab consolidation to CAR-T cell therapy in KMT2A-rearranged, therapy-related acute lymphoblastic leukemia. Pediatric Blood and Cancer 71(6), 2024. e-Pub 2024. PMID: 38514796.
39. Sheikh, IN, Alqahtani, S, Yin, CC, McCall, DC, Cuglievan, B, Ragoonanan, D, Connors, JS, Gibson, A, Nunez, CA, Roth, M, Ohanian, M, Borthakur, G, Garcia, MB. KIT-mutated pediatric core-binding factor systemic mastocytosis-acute myeloid leukemia treated with avapritinib and decitabine. Pediatric Blood and Cancer 71(4), 2024. e-Pub 2024. PMID: 38291730.
40. Short NJ, Jabbour E, Jamison T, Paul S, Cuglievan B, McCall D, Gibson A, Jain N, Haddad FG, Nasr LF, Marx KR, Rausch C, Savoy JM, Garris R, Ravandi F, Kantarjian H. Dose-Dense Mini-Hyper-CVD, Inotuzumab Ozogamicin and Blinatumomab Achieves Rapid MRD-Negativity in Philadelphia Chromosome-Negative B-cell Acute Lymphoblastic Leukemia. Clin Lymphoma Myeloma Leuk 24(4):e168-e173, 2024. e-Pub 2024. PMID: 38212207.
41. He, J, Munir, F, Catueno, S, Connors, JS, Gibson, A, Robusto, L, McCall, DC, Nunez, CA, Roth, M, Tewari, P, Garces, S, Cuglievan, B, Garcia, MB. Biological Markers of High-Risk Childhood Acute Lymphoblastic Leukemia. Cancers 16(5), 2024. e-Pub 2024. PMID: 38473221.
42. Bataller A, Abuasab T, McCall D, Wang W, Cuglievan B, Issa GC, Jabbour E, Short N, DiNardo CD, Tang G, Garcia-Manero G, Kantarjian HM, Sasaki K. Myeloid lineage switch in KMT2A-rearranged acute lymphoblastic leukemia treated with lymphoid lineagedirected therapies. Haematologica 109(1):293-297, 2024. e-Pub 2024. PMID: 37646654.
43. AlQahtani, McCall, Swinford R, Authement C. Dasatinib induced nephrotic syndrome in pediatric patient with acute lymphoblastic leukemia with hyper-eosinophilia. Journal of Onco-Nephrology, 2023. e-Pub 2023.
44. He J, Garcia MB, Connors JS, Nunez CA, Quesada AE, Gibson A, Roth M, Cuglievan B, Pemmaraju N, McCall D. Frontline Hyper-CVAD Plus Venetoclax for Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm. J Pediatr Hematol Oncol 45(8):e1001-e1004, 2023. e-Pub 2023. PMID: 37661300.
45. . The effectiveness of blinatumomab in clearing measurable residual disease in pediatric B-cell acute lymphoblastic leukemia patients detected by next-generation sequencing. Cancer Medicine. e-Pub 2023.
46. Ikawa Y. Strategy for pediatric patients with relapsed or refractory anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: a review. Cancers. e-Pub 2023.
47. Rav ES, Wahba A, Patnaik A, Toruner G, Hittle A, Toepfer L, Roth M, Cuglievan B, Nunez C, McCall D. A balancing act: Blinatumomab use in a rare occurrence of Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia in an adolescent patient with Down syndrome. Pediatr Blood Cancer 70(5):e30191, 2023. e-Pub 2023. PMID: 36602024.
48. Munir F, He J, Connors J, Garcia M, Gibson A, McCall D, Nunez C, Dinh CN, Robusto L, Roth M, Khazal S, Tewari P, Cuglievan B. Translational advances in the treatment of childhood acute lymphoblastic leukemia: narrative review of current and emerging molecular and immunotherapies. Transl Pediatr 12(3):487-502, 2023. e-Pub 2023. PMID: 37035397.
49. Trabal A, Gibson A, He J, McCall D, Roth M, Nunez C, Garcia M, Buzbee M, Toepfer L, Bidikian A, Daver N, Kadia T, Short NJ, Issa GC, Ravandi F, DiNardo CD, Montalban Bravo G, Garces S, Marcogliese A, Paek H, Dreyer Z, Brackett J, Redell M, Yi J, Garcia-Manero G, Konopleva M, Stevens A, Cuglievan B. Venetoclax for Acute Myeloid Leukemia in Pediatric Patients: A Texas Medical Center Experience. Cancers (Basel) 15(7), 2023. e-Pub 2023. PMID: 37046645.
50. McCall D, Jabbour E, Roth M, Nunez C, Cuglievan B. Mini-hyper CVD + CRIB (condensed rituximab, inotuzumab ozogamicin, and blinatumomab) for refractory pediatric B-acute lymphoblastic leukemia. Pediatr Blood Cancer 70(1):e29939, 2023. e-Pub 2023. PMID: 36031729.
51. Barth, M, Xavier, AG, Armenian, SH, Audino, AN, Blazin, L, Bloom, D, Chung, J, Davies, K, Ding, H, Ford, JB, Galardy, PJ, Rabi, H, Hayashi, RJ, Lee-Miller, C, Machnitz, AJ, Maloney, K, Marks, LJ, Martin, PL, McCall, DC, Pacheco, M, Reilly, A, Roshal, M, Song, S, Weinstein, JL, Zarnegar-Lumley, S, McMillian, NR, Schonfeld, R, Sundar, H. Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022. JNCCN Journal of the National Comprehensive Cancer Network 20(11):1267-1275, 2022. e-Pub 2022. PMID: 36351334.
52. McCall, D, Cuglievan, B. The Epigenetic Impact and Therapeutic Opportunity of AR-Directed Therapy For DSRCT, 2022. e-Pub 2022.
53. Lamhamedi-Cherradi SE, Maitituoheti M, Menegaz BA, Krishnan S, Vetter AM, Camacho P, Wu CC, Beird HC, Porter RW, Ingram DR, Ramamoorthy V, Mohiuddin S, McCall D, Truong DD, Cuglievan B, Futreal PA, Velasco AR, Anvar NE, Utama B, Titus M, Lazar AJ, Wang WL, Rodriguez-Aguayo C, Ratan R, Livingston JA, Rai K, MacLeod AR, Daw NC, Hayes-Jordan A, Ludwig JA. The androgen receptor is a therapeutic target in desmoplastic small round cell sarcoma. Nat Commun 13(1):3057, 2022. e-Pub 2022. PMID: 35650195.
54. Berkman AM, Andersen CR, Cuglievan B, McCall DC, Lupo PJ, Parsons SK, DiNardo CD, Short NJ, Jain N, Kadia TM, Livingston JA, Roth ME. Long-Term Outcomes among Adolescent and Young Adult Survivors of Acute Leukemia: A Surveillance, Epidemiology, and End Results Analysis. Cancer Epidemiol Biomarkers Prev 31(6):1176-1184, 2022. e-Pub 2022. PMID: 35553621.
55. Sheikh I, Nunez C, McCall D, Roth M, Cuglievan B. Programmed Cell Death Protein Blockade with Pembrolizumab for Classical Hodgkin Lymphoma after Autologous Stem Cell Transplantation in An Adolescent Patient. Pediatr Blood Cancer 69(3):e29390, 2022. e-Pub 2022. PMID: 35077016.
56. Molina, ER, Chim, LK, Lamhamedi-Cherradi, SE, Mohiuddin, S, McCall, DC, Cuglievan, B, Krishnan, S, Porter, RW, Ingram, D, Wang, W, Lazar, A, Scott, DW, Truong, D, Daw, NC, Ludwig, JA, Mikos, AG. Correlation of nuclear pIGF-1R/IGF-1R and YAP/TAZ in a tissue microarray with outcomes in osteosarcoma patients. Oncotarget 13:521-533, 2022. e-Pub 2022. PMID: 35284040.
57. Ragoonanan D, Bhar S, Mohan G, Beltramo F, Khazal SJ, Hurley C, Andersen C, Margossian S, Neelapu SS, Shpall E, Gutierrez C, Tewari P, Shoberu B, Talleur A, McCall D, Nunez C, Cuglievan B, Tambaro FP, Petropoulos D, Abdel-Azim H, Mahadeo KM. A multicenter study of ICU resource utilization in pediatric, adolescent and young adult patients post CAR-T therapy. Front Oncol 12:1022901, 2022. e-Pub 2022. PMID: 36353531.
58. Lamhamedi-Cherradi SE, Mohiuddin S, Mishra DK, Krishnan S, Velasco AR, Vetter AM, Pence K, McCall D, Truong DD, Cuglievan B, Menegaz BA, Utama B, Daw NC, Molina ER, Zielinski RJ, Livingston JA, Gorlick R, Mikos AG, Kim MP, Ludwig JA. Transcriptional activators YAP/TAZ and AXL orchestrate dedifferentiation, cell fate, and metastasis in human osteosarcoma. Cancer Gene Ther 28(12):1325-1338, 2021. e-Pub 2021. PMID: 33408328.
59. Gibson A, Trabal A, McCall D, Khazal S, Toepfer L, Bell DH, Roth M, Mahadeo KM, Nunez C, Short NJ, DiNardo C, Konopleva M, Issa GC, Ravandi F, Jain N, Borthakur G, Kantarjian HM, Jabbour E, Cuglievan B. Venetoclax for Children and Adolescents with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma. Cancers (Basel) 14(1), 2021. e-Pub 2021. PMID: 35008312.
60. McCall D, Roth M, Mahadeo KM, Toepfer L, Nunez C, Short NJ, Daver N, Kadia TM, DiNardo C, Yi JS, Cuglievan B. Gilteritinib Combination Therapies in Pediatric Patients with FLT3 Mutated Acute Myeloid Leukemia. Blood Adv 5(23):5215-5219, 2021. e-Pub 2021. PMID: 34592761.
61. Ragoonanan D, Khazal SJ, Abdel-Azim H, McCall D, Cuglievan B, Tambaro FP, Ahmad AH, Rowan CM, Gutierrez C, Schadler K, Li S, Di Nardo M, Chi L, Gulbis AM, Shoberu B, Mireles ME, McArthur J, Kapoor N, Miller J, Fitzgerald JC, Tewari P, Petropoulos D, Gill JB, Duncan CN, Lehmann LE, Hingorani S, Angelo JR, Swinford RD, Steiner ME, Hernandez Tejada FN, Martin PL, Auletta J, Choi SW, Bajwa R, Dailey Garnes N, Kebriaei P, Rezvani K, Wierda WG, Neelapu SS, Shpall EJ, Corbacioglu S, Mahadeo KM. Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer. Nat Rev Clin Oncol 18(7):435-453, 2021. e-Pub 2021. PMID: 33608690.
62. Nagalapuram V, McCall D, Palabindela P, Howard TH, Bemrich-Stolz C, Lebensburger J, Hilliard L, Wilson HP. Outcomes of Isolated Neutropenia Referred to Pediatric Hematology-Oncology Clinic. Pediatrics 146(4), 2020. e-Pub 2020. PMID: 32883808.
63. McCall D, Tewari P, Kass JDA, Cuglievan B. The Evolution of the Pediatric Hematology/Oncology Fellowship: What Does it Mean to be Productive?. J Pediatr Hematol Oncol 42(6):e544-e545, 2020. e-Pub 2020. PMID: 32032246.
64. Amin HM, Morani AC, Daw NC, Lamhamedi-Cherradi SE, Subbiah V, Menegaz BA, Vishwamitra D, Eskandari G, George B, Benjamin RS, Patel S, Song J, Lazar AJ, Wang WL, Kurzrock R, Pappo A, Anderson PM, Schwartz GK, Araujo D, Cuglievan B, Ratan R, McCall D, Mohiuddin S, Livingston JA, Molina ER, Naing A, Ludwig JA. IGF-1R/mTOR Targeted Therapy for Ewing Sarcoma: A Meta-Analysis of Five IGF-1R-Related Trials Matched to Proteomic and Radiologic Predictive Biomarkers. Cancers (Basel) 12(7):1-17, 2020. e-Pub 2020. PMID: 32630797.
65. Harden A, Ragoonanan D, Anildes-Gubman D, McCall D, Faltus K, Featherston S, Shoberu B, Moffet JR, Petropoulos D, Khazal SJ, Razvi S, Mahadeo KM, Tewari P. Chimeric Antigen Receptor, Teamwork, Education, Assessment, and Management (CAR-TEAM): A Simulation-Based Inter-professional Education (IPE) Intervention for Management of CAR Toxicities. Front Oncol 10:1227, 2020. e-Pub 2020. PMID: 32850365.
66. Molina ER, Chim LK, Salazar MC, Mehta SM, Menegaz BA, Lamhamedi-Cherradi SE, Satish T, Mohiuddin S, McCall D, Zaske AM, Cuglievan B, Lazar AJ, Scott DW, Grande-Allen JK, Ludwig JA, Mikos AG. Mechanically tunable coaxial electrospun models of YAP/TAZ mechanoresponse and IGF-1R activation in osteosarcoma. Acta Biomater 100:38-51, 2019. e-Pub 2019. PMID: 31542501.
67. Mahadeo KM, Khazal SJ, Abdel-Azim H, Fitzgerald JC, Taraseviciute A, Bollard CM, Tewari P, Duncan C, Traube C, McCall D, Steiner ME, Cheifetz IM, Lehmann LE, Mejia R, Slopis JM, Bajwa R, Kebriaei P, Martin PL, Moffet J, McArthur J, Petropoulos D, O'Hanlon Curry J, Featherston S, Foglesong J, Shoberu B, Gulbis A, Mireles ME, Hafemeister L, Nguyen C, Kapoor N, Rezvani K, Neelapu SS, Shpall EJ, (PALISI) Network PALIASI. Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy. Nat Rev Clin Oncol 16(1):45-63, 2019. e-Pub 2019. PMID: 30082906.
68. Khatua S, Mangum R, Bertrand KC, Zaky W, McCall D, Mack SC. Pediatric ependymoma: current treatment and newer therapeutic insights. Future Oncol 14(30):3175-3186, 2018. e-Pub 2018. PMID: 30418040.
69. Li, M, Bolduc, AR, Hoda, MN, Gamble, DN, Dolisca, SB, Bolduc, AK, Hoang, K, Ashley, C, McCall, DC, Rojiani, AM, Maria, BL, Rixe, O, MacDonald, T, Heeger, PS, Mellor, A, Munn, DH, Johnson, TS. The indoleamine 2,3-dioxygenase pathway controls complement-dependent enhancement of chemo-radiation therapy against murine glioblastoma. Journal for immunotherapy of cancer 2(1), 2014. e-Pub 2014. PMID: 25054064.

Invited Articles

1. McCall D, Catueno, Ramakrishnan, Tewari, Sheikh, Gibson, Nunez, Garcia, Cuglievan. Beyond cellular therapies: The expanding role of antibody-driven immunotherapy in pediatric acute lymphoblastic leukemia. e-Pub 2025.

Review Articles

1. McCall, DC, Catueno, S, Ramakrishnan, R, Tewari, P, Sheikh, IN, Gibson, A, Nunez, CA, Garcia, MB, Cuglievan, B. Beyond Cellular Therapies. Acta haematologica 149(1):84-100, 2026. e-Pub 2026. PMID: 40324358.
2. Cuglievan B, Kantarjian H, Rubnitz J, Cooper T, Zwaan M, Pollard J, DiNardo C, Tapan K, Guest E, Short N, McCall D, Daver N, Nunez C, Haddad, Garcia M, Bhalla K, Maiti A, Catueno S, Fiskus W, Gibson A, Roth M, Khazal S, Tewari P, Abbas H, Bourgeois W, Andreeff M, Shukla N, Truong D, Connors J, Ludwig J, Stutterheim J, Salzer E, Juul-Dam K, Sasaki K, Mahadeo K, Tasian S, Borthakur G, Dickson S, Jain N, Jabbour E, Meshinchi S, Garcia Manero G, Ravandi F, Stein E, Anders Kolb E., Issa G, Carter B. Menin Inhibitors in Pediatric Acute Leukemia: A Comprehensive Review and Recommendations in Collaboration with Adult Leukemia. Leukemia. e-Pub 2024.
3. Cuglievan B, Connors J, He J, Khazal S, Yedururi S, Dai J, Garces S, Quesada AE, Roth M, Garcia M, McCall D, Gibson A, Ragoonanan D, Petropoulos D, Tewari P, Nunez C, Mahadeo KM, Tasian SK, Lamble AJ, Pawlowska A, Hammond D, Maiti A, Haddad FG, Senapati J, Daver N, Gangat N, Konopleva M, Meshinchi S, Pemmaraju N. Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies. Leukemia 37(9):1767-1778, 2023. e-Pub 2023. PMID: 37452102.
4. Cuglievan B, McCall D, Robusto L, Mireles ME, Gettys SC. Current and Emerging Pharmacotherapy for the Treatment of childhood Acute Myeloid Leukemia. Expert Opin Pharmacother 23(17):1915-1925, 2022. e-Pub 2022. PMID: 36346029.

Editorials

1. Okeleji, O, McCall, DC, Gibson, A, Garcia, MB, Nunez, CA, Roth, M, Connors, JS, Petropoulos, D, Tewari, P, Cuglievan, B, Sheikh, IN. Post transplant maintenance therapy with newly FDA-approved revumenib for high-risk KMT2Ar acute leukemia. Blood Advances 9(8):1988-1990, 2025. PMID: 39993239.
2. McCall D, Karol S, Short NJ. The Need for Concurrent Chemoimmunotherapy in Pediatric B-Cell Lymphoblastic Leukemia.

Abstracts

1. McCall D, Maiti A, Daver N, Johnson WT, Goyal G, Broome CM, Gohil S, Laar JV, Jimenez JL, McCall D, Lane H, Kim B, Panicker S, Patou G, Moore S, Mangal B, Covert K, Parry GC, Dong K, Allen C, Iyer SP. Monoclonal Antibody Targeting Signal Regulatory Protein, Rapidly Controls Inflammation and Improves 2-Month Survival in Treatment-Naive Malignancy-Associated Hemophagocytic Lymphohistiocytosis. American Society of Hematology, 2024.
2. McCall D, Issa GC, Cuglievan B, Daver N, DiNardo CD, Farhat A, Short NJ, McCall D, Pike A, Tan S, Kammerer B, Marshal A, Yilmaz M, Kadia TM, Pemmaraju N, Maro, Ohanian, Abbas HA, Maiti A, Bazinet A, Jabbour E, Sasaki K, Borthakur G, Montalban-Bravo G, Jain N, Valero YA, Ravandi F, Garcia-Manero G, Andreeff M, Hagop M, Kantarjian. Phase I/II Study of the All-Oral Combination of Revumenib (SNDX-5613) with Decitabine/Cedazuridine (ASTX727) and Venetoclax (SAVE) in R/R AML. American Society of Hematology, 2024.
3. McCall D, Gibson A, Garcia MB, Nunez C, Roth ME, Cuglievan B. Phase II Study of Pedi-cRIB: Mini-Hyper-CVD with Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric Patients with B-Cell Lineage Acute Lymphocytic Leukemia. ASH 2024, 2024.
4. McCall D, Cuglievan B, Gibson A, Garcia MB, Roth ME, Nunez C. A Phase I Study Investigating the Combination of the Ziftomenib, Venetoclax and Azacitidine (ZiVA) in Pediatric Relapsed and Refractory Acute Leukemias. ASH 2024, 2024.
5. Li AM, Aftandilian C, Colace S, Fanizzi S, Faulk KE, Guest EM, Ammar, Hayani, Ho R, Khanna A, Leger K, McCall D, Miller TP, Pacenta H, Quigg T, Jeremy D, Rubinstein, Bhojwani D, Rheingold SR, O'Brien MM, Rabin KR. A Retrospective Study of Inotuzumab Ozogamicin in Individuals with Down Syndrome and B-Cell Acute Lymphoblastic Leukemia. American Society of Hematology, 2024.
6. Raj R, Catueno S, Gibson A, McCall D, Garcia MB, Nunez C, Roth ME, Sasaki K, Tewari P, Cuglievan B, DiNardo CD. FLAG IDA Venetoclax in Newly Diagnosed Pediatric and AYA Patients with AML. American Society of Hematology, 2024.
7. Alqahtani, McCall D, S, Munir, F, Nunez, C, Roth, M, Cuglievan, B, McCall, D. Rare Case Of Pediatric ALL With Concomitant Spinal Hemangioma Causing Paralegia And Pres. 2022 ASPHO Conference, 2023.
8. Tang Z, Kanagal-Shamanna R, Kantarjian HM, Garcia-Manero G, Cuglievan B, McCall D, Jain P, Robinson M, Reynolds A, Danos CP, Cardona GJ, Geiger CP, Yang S, Medeiros L, Toruner GA. Journal of Clinical Oncology. American Society of Clinical Oncology, 2023.
9. Bianchi MA, Iwase T, Ortega PT, Jiménez PJ, Izquierdo AR, Tycho, Baumann, Ubieto AJ, Sanchez-Bayona R, Pottier E, Shelton A, Pérez-García JM, Garcia-Mosquera JJ, Martinez-Bueno A, Hochberg EP, Martinez A, Nunez C, David, McCall, Ueno NT, Ciruelos EM, Cuglievan B. Journal of Clinical Oncology. American Society of Clinical Oncology, 2023.
10. Odetola, O, McCall, D, Gibson, A, Nunez, C, Cuglievan, B, Garcia, M, Roth, M. Early Unfavorable Classic Hodgkin Lymphoma Treated With A+AVD In a Pediatric Patient. 2023 ASPHO Conference, 2023.
11. He, McCall D, J, Garcia, M, Nunez, C A, Gibson, A, Cuglievan, B, Connors, J S, Roth, M. Remission With An Adult Regimen In A Teenager With Blastic Plasmacytoid Dendritic Cell Neoplasm. 2023 ASPHO Conference, 2023.
12. Rav, McCall D, E, Wahba, A, Cuglievan, B, Roth, M, Nunez, C, Toepfer, L, Hittle, A, McCall, D. A Balancing Act: Blinatumomab Use In A Rare Occurrence Of PH+ ALL In A Patient With Down Syndrome. 2022 ASPHO Conference, 2022.
13. Mohamed SF, McCall D, Abuasba T, Chien KS, Montalban-Bravo G, Darbaniyan F, Pierce SA, Soltysiak KA, Haddad F, McCall D, Cuglievan B, Jabbour EJ, Daver N, Kadia TM, Pemmaraju N, Kantarjian H, Garcia-Maner G. Characteristics and Outcomes of Adolescent and Young Adult (AYA) Patients with Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML): A Single-Center Retrospective Analysis. ASH, 2021.
14. Wahba, McCall D, A, Toepfer, L, Bell, D, Roth, M, McCall, D, Nunez, C, Cuglievan, B. Synchronous Leukemia and Ependymoma in A Pediatric Patient with no Genetic Predisposition. American Society of Pediatric Hematology Oncology, 2021.

Book Chapters

1. Tewari, P, Bajwa, R, Taraseviciute, A, Moffet, J, McCall, DC, Mahadeo, KM. Hematopoietic Stem Cell Transplant and Cellular Therapy, 109-158, 2019.
2. Tewari, P, Bajwa, R, Taraseviciute, A, Moffet, J, McCall, D, Mahadeo, K M. In Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient: An Evidence-Based Guide. In: Hematopoietic Stem Cell Transplant and Cellular Therapy. Switzerland, Springer International Publishing, 109-158, 2019.

Letters to the Editor

1. Frost, M, Elgehiny, A, Dobbins, C, Saleh, A, Rosemore, C, Hajjar, J, Abbas, HA, McCall, DC. Midostaurin–Cladribine Therapy for Neonatal Aggressive Systemic Mastocytosis. Pediatric Blood and Cancer 73, 2026.
2. Okeleji, O, McCall, DC, Cuglievan, B, Gibson, A, Petropoulos, D, Tewari, P, Connors, JS, Sheikh, IN. Immune-related toxicity profile after haematopoietic stem cell transplantation in patients with B-ALL given combination immunotherapy with rituximab, inotuzumab and blinatumomab. British Journal of Haematology 208: 1462-1466, 2026.
3. Cohen, E, Okeleji, O, McCall, DC, Garcia, MB, Nunez, CA, Cuglievan, B, Herzog, CE, Razvi, S, Tewari, P, Douglas, H, Gibson, A. Synchronous Mediastinal Germ Cell Tumor with Sarcomatous Transformation and Acute Myeloid Leukemia. Pediatric Blood and Cancer 72, 2025.